SynGenis is the brainchild of Prof Rakesh Veedu, a world-renowned oligonucleotide chemical biologist with over 15 years’ experience and over 100 publications and several patents in this field. After 6 years of running the oligonucleotide synthesis service out of the Murdoch University campus in Western Australia, SynGenis Pty Ltd was established in late 2020. The company moved to its own bigger facility in Bentley Technology Park, Western Australia with support from our initial investors. SynGenis is well set with highly experienced synthesis chemists and other supporting staff to provide high quality oligonucleotides in Australia, New Zealand, and the rest of the world.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 2/14 Brodie-Hall Dr, Bentley,western Australia 6102,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.syngenis.com
- HQ
- Bentley, Western Australia
Syngenis Questions
Syngenis's website is http://www.syngenis.com
Syngenis's LinkedIn profile is https://au.linkedin.com/company/syngenis
Syngenis has
7 employees.
View email and phone details for 7
employees at Syngenis.
Syngenis's industry is
Biotechnology Research
Syngenis's top competitors are
Epichem,
Speedx Pty Ltd,
Inventia Life Science,
Progenis Pharmaceuticals,
Genetic Signatures,
Lixa,
Perron Institute,
Linear Clinical Research,
Artrya Ltd,
Ausdiagnostics.
Syngenis's categories are Biotechnology Research
Syngenis's founding year is 2020
